Recent study results highlight need for new metrics in ECOG scoring to mitigate variability.
Liat Edry Botzer, PhD
Advertisement
Medical Director, Leal Health
Articles by Liat Edry Botzer, PhD
Advertisement
Latest Updated Articles
Rethinking ECOG Scores to Improve Patient Access and Clinical Trials EligibilityPublished: May 31st 2023 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Former FDA Commissioners Warn New Vaccine Policies Could Undermine Longstanding Regulatory Framework
2
How the FDA’s CNPV Program Is Reshaping Trial Operations and Accelerated Review Strategies
3
Voyxact Lands FDA Accelerated Approval Following Positive Results in Phase III VISIONARY Trial
4
ACT Brief: Targeted Trial Growth, Site Startup Strains, and Leadership Shake-Up at FDA
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
